These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 35287006)

  • 41. Management of Malignant Pleural Effusion: A Cost-Utility Analysis.
    Shafiq M; Frick KD; Lee H; Yarmus L; Feller-Kopman DJ
    J Bronchology Interv Pulmonol; 2015 Jul; 22(3):215-25. PubMed ID: 26165892
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outpatient talc administration via indwelling pleural catheters for malignant effusions.
    Dipper A; Bhatnagar R; Maskell N
    Curr Opin Pulm Med; 2019 Jul; 25(4):380-383. PubMed ID: 30998600
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Relationship of Pleural Manometry With Postthoracentesis Chest Radiographic Findings in Malignant Pleural Effusion.
    Chopra A; Judson MA; Doelken P; Maldonado F; Rahman NM; Huggins JT
    Chest; 2020 Feb; 157(2):421-426. PubMed ID: 31472154
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Malignant pleural effusion in the palliative care setting.
    Arber A; Clackson C; Dargan S
    Int J Palliat Nurs; 2013 Jul; 19(7):320, 322-5. PubMed ID: 24273808
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The use of indwelling pleural catheters for the treatment of malignant pleural effusions.
    Syer T; Walker S; Maskell N
    Expert Rev Respir Med; 2019 Jul; 13(7):659-664. PubMed ID: 31177915
    [No Abstract]   [Full Text] [Related]  

  • 46. Is Systemic Anticancer Therapy Associated With Higher Rates of Malignant Pleural Effusion Control in People With Pharmacologically Sensitive Tumors?: A Retrospective Analysis of Prospectively Collected Data.
    Holling N; Patole S; Medford ARL; Maskell NA; Bibby AC
    Chest; 2021 Nov; 160(5):1915-1924. PubMed ID: 34023321
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recent advances in the diagnosis and management of malignant pleural effusions.
    Heffner JE; Klein JS
    Mayo Clin Proc; 2008 Feb; 83(2):235-50. PubMed ID: 18241636
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thoracoscopic management of malignant pleural effusions.
    Colt HG
    Clin Chest Med; 1995 Sep; 16(3):505-18. PubMed ID: 8521705
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Malignant pleural effusion, current and evolving approaches for its diagnosis and management.
    Neragi-Miandoab S
    Lung Cancer; 2006 Oct; 54(1):1-9. PubMed ID: 16893591
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multidisciplinary approaches to the management of malignant pleural effusions: a guide for the clinician.
    Banka R; George V; Rahman NM
    Expert Rev Respir Med; 2020 Oct; 14(10):1009-1018. PubMed ID: 32634337
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Outpatient management of malignant pleural effusions with small-bore, tunneled pleural catheters.
    Musani AI; Haas AR; Seijo L; Wilby M; Sterman DH
    Respiration; 2004; 71(6):559-66. PubMed ID: 15627865
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interventional management of recurrent malignant pleural effusion: state of the art in 2021.
    Hajnikova Z; Michalek P; Votruba J; Zahorec R
    Bratisl Lek Listy; 2022; 123(1):50-54. PubMed ID: 34967658
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thoracoscopic collagen pleurodesis in the treatment of malignant pleural effusions.
    Akopov AL; Egorov VI; Varlamov VV; Levashev YN; Artioukh DY
    Eur J Cardiothorac Surg; 2005 Nov; 28(5):750-3. PubMed ID: 16198593
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Managing malignant pleural effusion.
    Wahla AS; Uzbeck M; El Sameed YA; Zoumot Z
    Cleve Clin J Med; 2019 Feb; 86(2):95-99. PubMed ID: 30742579
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Local biomaterial-assisted antitumour immunotherapy for effusions in the pleural and peritoneal cavities caused by malignancies.
    Sun Y; Hu Y; Wan C; Lovell JF; Jin H; Yang K
    Biomater Sci; 2021 Sep; 9(19):6381-6390. PubMed ID: 34582527
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Indwelling Pleural Catheters: A Clinical Option in Trapped Lung.
    Bertolaccini L; Viti A; Paiano S; Pomari C; Assante LR; Terzi A
    Thorac Surg Clin; 2017 Feb; 27(1):47-55. PubMed ID: 27865327
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions.
    Kolschmann S; Ballin A; Gillissen A
    Chest; 2005 Sep; 128(3):1431-5. PubMed ID: 16162739
    [TBL] [Abstract][Full Text] [Related]  

  • 58. OPTIMUM: a protocol for a multicentre randomised controlled trial comparing Out Patient Talc slurry via Indwelling pleural catheter for Malignant pleural effusion vs Usual inpatient Management.
    Sivakumar P; Douiri A; West A; Rao D; Warwick G; Chen T; Ahmed L
    BMJ Open; 2016 Oct; 6(10):e012795. PubMed ID: 27798020
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Surgical and other invasive approaches to recurrent pleural effusion with malignant etiology.
    Neragi-Miandoab S
    Support Care Cancer; 2008 Dec; 16(12):1323-31. PubMed ID: 18259780
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Palliation and pleurodesis in malignant pleural effusion: the role for tunneled pleural catheters.
    Suzuki K; Servais EL; Rizk NP; Solomon SB; Sima CS; Park BJ; Kachala SS; Zlobinsky M; Rusch VW; Adusumilli PS
    J Thorac Oncol; 2011 Apr; 6(4):762-7. PubMed ID: 21325982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.